Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Novo Nordisk A/S ADR (NVO)

Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 525,938,752
  • Shares Outstanding, K 4,487,532
  • Annual Sales, $ 33,724 M
  • Annual Income, $ 12,151 M
  • 60-Month Beta 0.42
  • Price/Sales 15.68
  • Price/Cash Flow 38.23
  • Price/Book 31.82
Trade NVO with:

Options Overview Details

View History
  • Implied Volatility 39.43% ( +0.32%)
  • Historical Volatility 31.76%
  • IV Percentile 97%
  • IV Rank 62.64%
  • IV High 49.01% on 08/05/24
  • IV Low 23.37% on 06/12/24
  • Put/Call Vol Ratio 0.96
  • Today's Volume 17,439
  • Volume Avg (30-Day) 24,931
  • Put/Call OI Ratio 0.90
  • Today's Open Interest 278,521
  • Open Int (30-Day) 260,004

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 0.88
  • Number of Estimates 3
  • High Estimate 0.89
  • Low Estimate 0.87
  • Prior Year 0.73
  • Growth Rate Est. (year over year) +20.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
113.79 +2.82%
on 10/04/24
138.22 -15.35%
on 09/16/24
-14.91 (-11.30%)
since 09/09/24
3-Month
113.79 +2.82%
on 10/04/24
143.49 -18.46%
on 07/15/24
-23.43 (-16.68%)
since 07/09/24
52-Week
91.90 +27.31%
on 10/10/23
148.15 -21.03%
on 06/25/24
+24.94 (+27.09%)
since 10/09/23

Most Recent Stories

More News
De Grey Reaches A$7M Minimum Spend at Egina Gold Project and Continues Investment

NVO-WT.TO : 0.01 (unch)
NSRPF : 0.0725 (+10.18%)
NVO.AX : 0.099 (+6.45%)
NVO : 117.00 (-0.17%)
DEG : 28.11 (-0.07%)
NVO.TO : 0.0850 (-5.56%)
Implied Volatility Surging for Novo Nordisk (NVO) Stock Options

Investors in Novo Nordisk A/S NVO need to pay close attention to the stock based on moves in the options market lately. That is because the Jan. 17, 2025 $25.00 Call had some of the highest implied volatility...

NVO : 117.00 (-0.17%)
Got $5,000? These 3 Growth Stocks Are on Sale Right Now.

These stocks are all down 14% or more in the past three months.

CELH : 30.51 (+6.16%)
NVO : 117.00 (-0.17%)
DELL : 122.34 (+0.34%)
Pfizer Receives $1 Billion From Starboard Value, Stock Rises

Shares of Pfizer PFE rose 2.17% on Oct. 7 after a report from The Wall Street Journal stated that activist investor Starboard Value has taken a roughly $1 billion stake in the company.Investors cheered...

NVO : 117.00 (-0.17%)
LLY : 919.74 (+0.66%)
PFE : 30.19 (+3.46%)
Prediction: 3 of Wall Street's Most Influential Stocks Can Plunge if Kamala Harris Wins in November

A victory for the current vice president on Nov. 5 may be bad news for three market-leading businesses.

META : 590.51 (-0.40%)
AAPL : 229.54 (+1.67%)
NVO : 117.00 (-0.17%)
Billion-Dollar News for Eli Lilly Stock Investors

Eli Lilly shares have soared thanks to excitement about the company's position in the weight loss drug market.

NVO : 117.00 (-0.17%)
LLY : 919.74 (+0.66%)
GS : 505.18 (+1.73%)
Novo Nordisk Stock Down Into Oversold Territory: Time to Buy?

Shares of Ozempic-maker Novo Nordisk (NYSE:NVO) have been nosediving in recent weeks. And in the past ...

NVO : 117.00 (-0.17%)
Prediction: These 2 Stocks Will Join Nvidia, Meta, Apple, Amazon, and Microsoft in the Trillion-Dollar Club by 2030

These companies have been on fire for a while, but they haven't peaked yet.

MSFT : 417.46 (+0.66%)
NVDA : 132.65 (-0.18%)
META : 590.51 (-0.40%)
AAPL : 229.54 (+1.67%)
MA : 499.95 (+0.72%)
V : 276.93 (+0.72%)
NVO : 117.00 (-0.17%)
AMZN : 185.17 (+1.34%)
3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn't Ignore

Check out these three micro-cap companies that have a big opportunity to succeed, but also significant a risk of failure.

NVDA : 132.65 (-0.18%)
SKYE : 3.74 (-3.36%)
NVO : 117.00 (-0.17%)
SPWR : 0.1228 (-5.47%)
SCWO : 1.4400 (unch)
RENT : 10.20 (+8.86%)
US Port Strike Threatens Supply of Popular Weight-Loss Drugs Ozempic, Wegovy, Mounjaro, and Zepbound

The ongoing US port strike on the East and Gulf coasts is causing significant disruptions to pharmaceutical supply chains, particularly for the popular weight-loss drugs Wegovy, Ozempic, Mounjaro, and...

NVO : 117.00 (-0.17%)
LLY : 919.74 (+0.66%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Bagsv'rd, Denmark-based Novo Nordisk is a global healthcare company and a leader in the worldwide diabetes market. The company is also a key player in hemophilia care, growth hormone therapy, hormone replacement therapy and obesity.Novo Nordisk operates through two segments: Diabetes and obesity care...

See More

Key Turning Points

3rd Resistance Point 118.84
2nd Resistance Point 118.00
1st Resistance Point 117.50
Last Price 117.00
1st Support Level 116.16
2nd Support Level 115.32
3rd Support Level 114.82

See More

52-Week High 148.15
Fibonacci 61.8% 126.66
Fibonacci 50% 120.02
Last Price 117.00
Fibonacci 38.2% 113.39
52-Week Low 91.90

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar